Table 2.
Origin and diagnostic results of TB inpatients at CHEO (1998-2008)
| Case/age (y)/sex | Residence | Birth country | PC | HIV status | TST (mm) | CXR | Cx | TB disease site(s) | |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 17 m | Ottawa | Somalia | - | U | n/a | - | + | Spine |
| 2 | 12 f | Ottawa | Somalia | - | - | 26 | + | + | Adult-type |
| 3 | 14 f | Ottawa | Somalia | - | U | 27 | + | + | Abdominal |
| 4 | 12 f | Baffin | Canada | + | U | 27 | + | + | Adult-type |
| 5 | 1 f | Quebec | Canada | + | U | 22 | + | + | Primary pulmonary |
| 6 | 14 m | UK | UK | - | U | n/a | + | + | Pleural |
| 7 | 6 f | Ottawa | Somalia | - | U | 16 | + | + | Primary pulmonary |
| 8 | 11 m | Quebec | Canada | - | - | 19 | + | - | Primary pulmonary |
| 9 | 6 f | Ottawa | Rwanda | - | + | n/a | - | + | CNS and abdominal |
| 10 | 8 f | Quebec | Canada | + | U | 20 | + | - | Primary pulmonary |
| 11 | 15 f | Ottawa | Zambia | - | U | n/a | + | + | Pleural |
| 12 | 13 m | Baffin | Canada | + | U | n/a | + | + | CNS and miliary |
| 13 | 17 f | Ottawa | Somalia | - | U | n/a | + | + | Superficial LN and primary pulmonary |
| 14 | 1 m | Baffin | Canada | + | - | 25 | + | - | Primary pulmonary |
| 15 | 1 m | Baffin | Canada | + | U | 22 | + | + | Primary pulmonary |
| 16 | 1 m | Baffin | Canada | - | U | 40 | + | + | Primary pulmonary |
| 17 | 4 m | Baffin | Canada | + | U | n/a | - | - | CNS |
| 18 | 1 m | Quebec | Canada | - | U | 14 | + | + | Primary pulmonary |
| 19 | 14 f | Baffin | Canada | + | U | 22 | + | - | Pleural |
| 20 | 17 m | Haiti | US | - | - | 20 | + | + | Adult-type |
PC: proven contact; TST: tuberculin skin test; CXR: chest x-ray; Cx: culture; m: male; f: female; U: unknown; "Quebec" refers to region of western Quebec serviced by CHEO; UK: United Kingdom; US: United States; CNS: central nervous system; LN: lymph node